Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Lao-Sirieix

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Nature Reviews. Clinical Oncology|March 21, 2012
Screening for oesophageal cancerPierre Lao-Sirieix, Rebecca C Fitzgerald
Biochemical Society Transactions|March 20, 2010
Role of the micro-environment in Barrett's carcinogenesisPierre Lao-Sirieix, Rebecca C Fitzgerald
Current Opinion in Genetics & Development|March 30, 2010
Genetic predisposition to gastro-oesophageal cancerPierre Lao-Sirieix, Carlos Caldas, Rebecca C Fitzgerald
Biomarkers in Medicine|June 11, 2011
Developing a nonendoscopic screening test for Barrett's esophagusSudarshan Kadri, Pierre Lao-Sirieix, Rebecca C Fitzgerald
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Cyclin A immunocytology as a risk stratification tool for Barrett's esophagus surveillancePierre Lao-Sirieix, Laurence Lovat, Rebecca C Fitzgerald
World Journal of Gastroenterology|December 4, 2010
Biomarkers in Barrett's esophagus and esophageal adenocarcinoma: predictors of progression and prognosisChin-Ann J Ong, Pierre Lao-Sirieix, Rebecca C Fitzgerald
The Cochrane Database of Systematic Reviews|March 4, 2021
Treatment for Barrett's oesophagusJonathan Re Rees, Pierre Lao-Sirieix, Angela Wong, et al.
The Cochrane Database of Systematic Reviews|January 22, 2010
Treatment for Barrett's oesophagusJonathan Re Rees, Pierre Lao-Sirieix, Angela Wong, et al.
Neoplasia (New York, N.Y.)|February 22, 2005
Cell cycle phase abnormalities do not account for disordered proliferation in Barrett's carcinogenesisPierre Lao-Sirieix, Rebecca Brais, Laurence Lovat, et al.
Plos One|February 1, 2007
Selective loss of TGFbeta Smad-dependent signalling prevents cell cycle arrest and promotes invasion in oesophageal adenocarcinoma cell linesBenjamin A Onwuegbusi, Jonathan R E Rees, Pierre Lao-Sirieix, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Nature Reviews. Clinical Oncology|March 21, 2012
Screening for oesophageal cancerPierre Lao-Sirieix, Rebecca C Fitzgerald
Biochemical Society Transactions|March 20, 2010
Role of the micro-environment in Barrett's carcinogenesisPierre Lao-Sirieix, Rebecca C Fitzgerald
Current Opinion in Genetics & Development|March 30, 2010
Genetic predisposition to gastro-oesophageal cancerPierre Lao-Sirieix, Carlos Caldas, Rebecca C Fitzgerald
Biomarkers in Medicine|June 11, 2011
Developing a nonendoscopic screening test for Barrett's esophagusSudarshan Kadri, Pierre Lao-Sirieix, Rebecca C Fitzgerald
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Cyclin A immunocytology as a risk stratification tool for Barrett's esophagus surveillancePierre Lao-Sirieix, Laurence Lovat, Rebecca C Fitzgerald
World Journal of Gastroenterology|December 4, 2010
Biomarkers in Barrett's esophagus and esophageal adenocarcinoma: predictors of progression and prognosisChin-Ann J Ong, Pierre Lao-Sirieix, Rebecca C Fitzgerald
The Cochrane Database of Systematic Reviews|March 4, 2021
Treatment for Barrett's oesophagusJonathan Re Rees, Pierre Lao-Sirieix, Angela Wong, et al.
The Cochrane Database of Systematic Reviews|January 22, 2010
Treatment for Barrett's oesophagusJonathan Re Rees, Pierre Lao-Sirieix, Angela Wong, et al.
Neoplasia (New York, N.Y.)|February 22, 2005
Cell cycle phase abnormalities do not account for disordered proliferation in Barrett's carcinogenesisPierre Lao-Sirieix, Rebecca Brais, Laurence Lovat, et al.
Plos One|February 1, 2007
Selective loss of TGFbeta Smad-dependent signalling prevents cell cycle arrest and promotes invasion in oesophageal adenocarcinoma cell linesBenjamin A Onwuegbusi, Jonathan R E Rees, Pierre Lao-Sirieix, et al.
Pageof 5